This federal contract award, identified as SPE2DB24D8001 and SPE2DB25FKYYT, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of $2,994.06 and a performance period through December 27, 2024. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, including items such as insulin pens, auto-injectors, inhalers, and various medications. This award is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of medical items to support U.S. Armed Forces healthcare operations. The contract is a firm fixed-price arrangement and does not have a set-aside designation.
Generated 3/27/25, 10:03 AM